Clinical Trials in East London, South Africa
5 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,580 enrolled27 locationsNCT07071623
Recruiting
Phase 2Phase 3
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Breast Neoplasms
Bristol-Myers Squibb500 enrolled293 locationsNCT06926868
Recruiting
Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
AstraZeneca11,300 enrolled917 locationsNCT06677060
Recruiting
Not Applicable
Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis
Drug Resistant TuberculosisRifampin-resistant Tuberculosis
Albert Einstein College of Medicine280 enrolled1 locationNCT06590428
Recruiting
Not Applicable
Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment
Drug Resistant Tuberculosis
Johns Hopkins University2,944 enrolled5 locationsNCT05671718
Recruiting
Not Applicable
Assessing the Feasibility of Coach Mpilo for Men With TB and HIV
TuberculosisHIV
Arizona State University240 enrolled1 locationNCT07117370
Recruiting
Not Applicable
Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging
HIV InfectionsTreatment AdherenceMen
Desmond Tutu HIV Foundation3,642 enrolled2 locationsNCT05602376
Recruiting
Not Applicable
Tailoring Healthy Relationships to Improve HIV Outcomes
HIV
Arizona State University120 enrolled1 locationNCT05708261